Taysha Gene Therapies Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 23.56 M | $129.56 M | 0.00% | 6.67% |
| AVORO CAPITAL ADVISORS LLC | 02/17/2026 | 21.70 M | $119.35 M | 0.00% | 6.14% |
| BLACKROCK, INC. | 02/12/2026 | 18.64 M | $102.54 M | 13.92% | 5.28% |
| MORGAN STANLEY | 02/13/2026 | 18.08 M | $99.43 M | -6.37% | 5.12% |
| RTW INVESTMENTS, LP | 02/17/2026 | 16.40 M | $90.19 M | -32.67% | 4.64% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 13.75 M | $75.63 M | 150.00% | 3.89% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 13.69 M | $75.31 M | 2.31% | 3.88% |
| VANGUARD GROUP INC | 01/29/2026 | 13.27 M | $72.97 M | 3.25% | 3.76% |
| STATE STREET CORP | 02/13/2026 | 10.79 M | $59.35 M | 49.11% | 3.05% |
| SIREN, L.L.C. | 02/13/2026 | 10.13 M | $55.71 M | -8.03% | 2.87% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 8.86 M | $48.73 M | -2.29% | 2.51% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 7.93 M | $43.62 M | 49.82% | 2.24% |
| BARCLAYS PLC | 02/13/2026 | 5.54 M | $30.46 M | 7.59% | 1.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.39 M | $29.63 M | 4.11% | 1.52% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 4.00 M | $22.03 M | 0.00% | 1.13% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 3.72 M | $20.47 M | 100.00% | 1.05% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 3.30 M | $18.15 M | 10.00% | 0.93% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.18 M | $17.48 M | -21.04% | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 2.72 M | $14.97 M | -49.46% | 0.77% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 2.50 M | $13.73 M | -11.99% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.90 M | $10.47 M | 3.06% | 0.54% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.85 M | $10.20 M | 404.98% | 0.53% |
| NORGES BANK | 02/10/2026 | 1.84 M | $10.11 M | 100.00% | 0.52% |
| B GROUP, INC. | 02/17/2026 | 1.80 M | $9.90 M | 0.00% | 0.51% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 1.50 M | $8.25 M | 100.00% | 0.42% |
| INVESCO LTD. | 02/19/2026 | 1.33 M | $7.33 M | 376.35% | 0.38% |
| 02/17/2026 | 1.33 M | $7.32 B | 100.00% | 0.38% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.33 M | $7.30 M | -60.10% | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 1.27 M | $6.99 M | 119.79% | 0.36% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.24 M | $6.81 M | -27.91% | 0.35% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.15 M | $6.34 M | -11.83% | 0.33% |
| ABRDN PLC | 01/16/2026 | 1.02 M | $5.62 M | 100.00% | 0.29% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 980.77 K | $5.39 M | 100.00% | 0.28% |
| EAM INVESTORS, LLC | 02/12/2026 | 823.76 K | $4.53 M | 100.00% | 0.23% |
| QUANTUM PRIVATE WEALTH, LLC | 02/06/2026 | 819.72 K | $4.51 M | -0.29% | 0.23% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 781.47 K | $4.30 M | 2,271.77% | 0.22% |
| JPMORGAN CHASE & CO | 02/11/2026 | 774.41 K | $4.26 M | 161.41% | 0.22% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2026 | 724.87 K | $3.99 M | 0.00% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 711.24 K | $3.91 M | 25.22% | 0.20% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 703.97 K | $3.87 M | -36.96% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 624.37 K | $3.43 M | -0.08% | 0.18% |
| NUVEEN, LLC | 02/12/2026 | 545.29 K | $3.00 M | 7.51% | 0.15% |
| WOODLINE PARTNERS LP | 02/17/2026 | 500.00 K | $2.75 M | 0.00% | 0.14% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 490.70 K | $2.70 M | 100.00% | 0.14% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 490.47 K | $2.70 M | 42.10% | 0.14% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 471.58 K | $2.59 M | 137.75% | 0.13% |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 454.83 K | $2.50 M | 0.00% | 0.13% |
| HRT FINANCIAL LP | 02/12/2026 | 409.25 K | $2.25 M | 100.00% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 383.04 K | $2.11 M | -40.09% | 0.11% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 368.15 K | $2.02 M | -9.80% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Taysha Gene Therapies Inc institutional Ownership - FAQ's
During the previous two years, 174 institutional investors and hedge funds held shares of Taysha Gene Therapies Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 18.64 M
MORGAN STANLEY: 18.08 M
GOLDMAN SACHS GROUP INC: 13.69 M
VANGUARD GROUP INC: 13.27 M
STATE STREET CORP: 10.79 M
Siren, L.L.C.: 10.13 M
41.02% of Taysha Gene Therapies Inc stock is owned by institutional investors.
Institutional investors have bought a total of 147.52 M shares in the last 24 months. This purchase volume represents approximately $693.32 M in transactions.